Increasing Diagnostic Yield in Hereditary Peripheral Neuropathy
This presentation, recorded on August 9, 2017, offers an educational overview of the large category of peripheral neuropathies, with a focus on identifying hereditary neuropathies. Various testing platforms and their strengths and weaknesses will be discussed in diagnosing affected patients. Cases will be used to illustrate the points.
- Discuss next-generation sequencing technology.
- Recognize strengths and weaknesses of various platforms.
- Commit to becoming a critical user of this technology in routine clinical practice.
Christopher Klein, M.D.
Professor of Neurology, College of Medicine
This webinar is designed for any provider who sees patients with a neurologic disease (e.g., neurologists; psychiatrists; and primary care physicians, including internists and family care practitioners) as well as pathologists, laboratory directors, and laboratory sendout coordinators.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
National Physician Payment Transparency Program
Mayo Medical Laboratories is not an applicable manufacturer or applicable group purchasing organization (GPO). (GPOs, per the Centers for Medicare & Medicaid Services, and this program, do not trigger any reporting requirements pursuant to Open Payments [Sunshine Act] legislation.)